Why at-home care could lead to better staff retention

The latest stories trending on MedCity News.

Editor's Pick

Top Story Current Health CEO: At-Home Care Models Could Lead to Better Staff Retention Many healthcare workers prefer providing at-home care because it allows them to provide more personal, less hectic care than they can on the hospital floor, said Current Health CEO Chris McGhee. He thinks health systems should realize that switching more healthcare workers to at-home care could help alleviate the burnout crisis and improve staff retention levels. "The Best Event" Get Your Front Row Seat Don't take our word for it. Past attendees comment on the event. J. June, CEO of Ischemia Care, said, "Great networking, venue was outstanding, a lot of fun. This was without a doubt the best event of its type I have ever attended." And P. Burton, CEO of ResQ Pharma, said, "Very well managed. Speakers and panelists were outstanding. Content and subject matters covered during presentations were excellent. Overall I had an outstanding experience!" Hurry, You Can Still Save $400 [Ends 4/7] - Register Today!

Featured News

Data Governance: Addressing Data Defense and Offense Proper data governance is essential to ensure the efficient and accurate operation of an organization. It involves creating static rules, dynamic management processes and a comprehensive set of business objectives which must be met to protect the integrity of data within the system. Tackling Misconceptions of Influencer Marketing with Patients Can Benefit Healthcare Industry Over the past decade, influencer marketing has become a popular tool for brands looking to […] Common Mistakes In Medical Device Labeling And How To Avoid Them Labels may be small and simple items, but they have a huge part to play in patient health, and any hospital or healthcare institution that wants to keep patients safe should absolutely invest in adequate labeling methods moving forward. Cytokinetics Stops ALS Program After Analysis Finds No Evidence of Effect Cytokinetics drug reldesemtiv has failed a pivotal clinical trial in amyotrophic lateral sclerosis. The small molecule had previously failed in Phase 2, but the biotech believed adjustments could lead to better results in Phase 3.

Resources

MedCity Moves Podcast: Recent Hires and Layoffs In this month's episode, we dive into some of the recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Tom Richards, who recently became the new executive vice president of business development at Transcarent after spending more than 35 years at Cigna. Listen Now

MedCity News • 611 Broadway • New York, NY unsubscribe